NM

Nirmala Manjunath Skanda Prasad

Active Director Director DIN 11619344
DIN 11619344 First appointment Mar 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Nirmala Manjunath Skanda Prasad

Data last updated:

Nirmala Manjunath Skanda Prasad is a Director at Medrx Health Care Private Limited (since 2026).

DIN 11619344
Primary Designation Director
First Appointment 19 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medrx Health Care Private Limited U26600KA2026PTC218021
Director19 Mar 20262026Active

Board colleagues of Nirmala Manjunath Skanda Prasad

Directorship timeline

Open interactive timeline →
Medrx Health Care Private Limited
Premium access

Shareholding and investment profile for Nirmala Manjunath Skanda Prasad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nirmala Manjunath Skanda Prasad

Nirmala Manjunath Skanda Prasad currently holds 1 directorship: Medrx Health Care Private Limited (Director, since 19 Mar 2026).

Nirmala Manjunath Skanda Prasad was first appointed on 19 Mar 2026 as Director at Medrx Health Care Private Limited.

The current boards of Nirmala Manjunath Skanda Prasad's companies include Pagadalu Dharanipathi Chandhana (Medrx Health Care Private Limited), Somahalli Vijayakumar Shreemanth Kumar (Medrx Health Care Private Limited), Srinivas Mohan (Medrx Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available